SCT in RS
Reference . | Patients . | Age <60 y, % . | Transplant . | CR/PR at transplant, % . | RIC, % . | VUD, % . | 3-y relapse, % . | 3-y RFS, % . | NRM, % . | 3-y OS, % . | Prognostic factors . |
---|---|---|---|---|---|---|---|---|---|---|---|
46 | 17 | 52 | Allogeneic | 41 | na | 52 | na | na | na | 75 (if remission at transplant) | Remission at transplant |
59 | 25 | 60 | Allogeneic | 60 | 72 | 44 | 47 | 27 | 26 | 36 | • Remission at transplant |
• Age <60 y | |||||||||||
• RIC | |||||||||||
59 | 34 | 65 | Autologous | 82% | — | — | 43 | 45 | 12 | 59 | None |
Reference . | Patients . | Age <60 y, % . | Transplant . | CR/PR at transplant, % . | RIC, % . | VUD, % . | 3-y relapse, % . | 3-y RFS, % . | NRM, % . | 3-y OS, % . | Prognostic factors . |
---|---|---|---|---|---|---|---|---|---|---|---|
46 | 17 | 52 | Allogeneic | 41 | na | 52 | na | na | na | 75 (if remission at transplant) | Remission at transplant |
59 | 25 | 60 | Allogeneic | 60 | 72 | 44 | 47 | 27 | 26 | 36 | • Remission at transplant |
• Age <60 y | |||||||||||
• RIC | |||||||||||
59 | 34 | 65 | Autologous | 82% | — | — | 43 | 45 | 12 | 59 | None |
CR, complete response; NRM, nonrelapse mortality; OS, overall survival; PR, partial response; RFS, relapse-free survival; RIC, reduced-intensity conditioning; VUD, volunteer unrelated donor.